Pharmarise Holdings Corp. (2796) Stock Statistics & Valuation Metrics

Pharmarise Holdings Corp. has a market cap or net worth of ¥5.58B. The enterprise value is ¥18.21B.

Pharmarise Holdings Corp. has 12,060,381 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharmarise Holdings Corp.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.64%.

The current PE Ratio of Pharmarise Holdings Corp. is 47.3. Pharmarise Holdings Corp.’s PEG ratio is -0.39.

In the last 12 months, Pharmarise Holdings Corp. had revenue of 69.51B and earned 113.00M in profits. Earnings per share was 9.95.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Pharmarise Holdings Corp. pays an annual dividend of ¥14, resulting in a dividend yield of 2.65%

Pharmarise Holdings Corp. upcoming earnings date is Oct 8, 2026, TBA (Confirmed).

Pharmarise Holdings Corp. as a current ratio of 0.94, with Debt / Equity ratio of 221.46%

In the past 12 months, Pharmarise Holdings Corp. has paid 591.00M in taxes.

Pharmarise Holdings Corp. EV to EBITDA ratio is 15.23, with an EV/FCF ratio of 5.78.

Pharmarise Holdings Corp. has ¥2.12B in cash and marketable securities with ¥13.03B in debt, giving a net cash position of -¥10.91B billion.

Gross margin is 12.42%, with operating margin of 1.41%, and net profit margin of 0.16%.

The average price target for Pharmarise Holdings Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―